Representatives of MIT at the III All-Russian Congress “Nuclear Medicine — 2024” in St. Petersburg
Employees of MIT participated in the III All-Russian Congress with International Participation “Nuclear Medicine — 2024,” held in St. Petersburg.
The scientific program of the event covered key aspects of modern nuclear medicine, including:
- Radionuclide imaging for the diagnosis of oncological, cardiological, endocrinological, and neurological diseases.
- Radionuclide therapy and theranostics of oncological pathologies.
- Development, production, and quality control of radiopharmaceuticals.
- Production of precursors and kits for the synthesis of radiopharmaceutical drugs.
- Preclinical studies of radiopharmaceuticals.
- Development and creation of equipment for nuclear medicine.
- Radiation safety and legal aspects in the field of nuclear medicine.
- Training of qualified specialists for the industry.
Participation in the congress provided an opportunity to discuss current trends, establish new contacts, and share experiences in the development and implementation of advanced nuclear medicine technologies.
MIT specializes in the comprehensive equipping of oncology and nuclear medicine centers, providing the supply of modern equipment and solutions.
MIT is the official distributor of leading global manufacturers, including Elekta, GE Healthcare, Comecer, Orfit, Ulrich, Sanova, PTW, LAP, and ABX advanced biochemical. A professional approach and partnerships with industry leaders make MIT a reliable partner for medical institutions striving to develop and implement innovative diagnostic and treatment methods.
